ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation

 In today’s ACT Brief, we highlight new insights on recruitment bottlenecks from Citeline’s Matt Holms, UCB’s first-in-class approval for TK2 deficiency, and why strong data foundations are key to realizing AI’s full potential in pharma.